MADRIGAL PHARMACEUTICALS, INC. ($MDGL)
Filing Information
| Accession Number | 0001628280-26-015758 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
9,394
Total Value
$180,982.86
P&L
+inf% (+$3,959,411.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Mar 4, 2026 | Grant/Award | 3,989 | $0.00 | $0.00 | 13,111 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Mar 6, 2026 | Sale | 419 | $431.94 | $180,982.86 | 12,692 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Mar 4, 2026 | Grant/Award | 4,986 | $0.00 | $0.00 | 4,986 | Direct | โ | View Details |